# South Korea Coronary Angiography Devices Market

> South Korea Coronary Angiography Devices Market Research Report By Product Type (Angiography Catheters, Contrast Media, Angiography Systems, Inflatable Balloons, Guidewires), By Application (Coronary Angiography, Peripheral Angiography, Neuro Angiography, Interventional Angiography), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Specialty Clinics), and By Technology (Digital Angiography, Computed Tomography Angiography, Magnetic Resonance Angiography) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.22%
- **2024:** $ 300 Million
- **2025:** $ 336.66 Million
- **2035:** $ 1,066 Million
- **Key Players:** Abbott (US), Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Cardinal Health (US), Terumo (JP), B. Braun (DE)

**Report ID:** MRFR/HC/54493-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-coronary-angiography-devices-market-56259

---

## Market Summary

## **South Korea Coronary Angiography Devices Market Overview**

As per MRFR analysis, the South Korea Coronary Angiography Devices Market Size was estimated at 319.4 (USD Million) in 2023. The South Korea Coronary Angiography Devices Market is expected to grow from 334.2 (USD Million) in 2024 to 667 (USD Million) by 2035. The South Korea Coronary Angiography Devices Market CAGR (growth rate) is expected to be around 6.484% during the forecast period (2025 - 2035).

## **Key South Korea Coronary Angiography Devices Market Trends Highlighted**

Significant changes in the South Korean market for coronary angiography devices are being influenced. Both rising healthcare demands and technical advancements play a role. The combination of cutting-edge imaging technologies, like intravascular ultrasound and 3D imaging, is revolutionizing patient outcomes and diagnostic accuracy.

In response to the increasing incidence of cardiovascular disorders, South Korea, with its sophisticated healthcare infrastructure, prioritizes advanced angiography technology adoption. The need for efficient cardiac interventions is increasing due to the aging population. This forces medical professionals to invest in state-of-the-art machinery.

Government programs supporting early illness identification and treatment, such as the country's healthcare policies prioritizing cardiovascular health, are important market drivers. Furthermore, the existence of prominent medical device producers in South Korea creates a favorable atmosphere for innovation. This guarantees that the market stays competitive and progressive.

Telemedicine and remote monitoring technologies present new opportunities to improve patient treatment and follow-up procedures. This change aligns with South Korea's objective of incorporating intelligent healthcare technologies into pre-existing structures. There has been a discernible shift toward minimally invasive procedures in recent years.

These are favored by patients and medical professionals alike since they need less recovery time and have a lower risk of problems. The field of coronary angiography is also changing due to the growth of customized medicine. This involves customizing therapies for each patient.

This market will probably develop further as South Korea prioritizes health and keeps up with technology advancements. This follows the guidelines established by national and international healthcare trends.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **South Korea Coronary Angiography Devices Market Drivers**

### **Increasing Prevalence of Cardiovascular Diseases**

The South Korea [Coronary Angiography Devices](../../../reports/coronary-angiography-devices-market-6151) Market is significantly driven by the rising prevalence of cardiovascular diseases. According to the Korea Centers for Disease Control and Prevention, cardiovascular diseases consistently remained the leading cause of death. They account for approximately 30% of total deaths in recent years.

This statistic highlights a pressing need for preventive and diagnostic measures, including coronary angiography devices. Moreover, increasing sedentary lifestyles and dietary shifts among the South Korean population have led to a surge. This surge is in hypertension and heart-related conditions, further propelling demand.

Organizations like the Korean Society of Cardiology advocate for enhanced investment in cardiovascular health. This is anticipated to foster a robust growth trajectory for the South Korea Coronary Angiography Devices Market.

### **Technological Advancements in Imaging Techniques**

Technological advancements are playing a crucial role in shaping the South Korea Coronary Angiography Devices Market. Innovations such as 3D imaging, high-definition digital cameras, and real-time imaging software have transformed accuracy. They also transform the effectiveness of coronary angiography procedures.

The Ministry of Health and Welfare of South Korea has been actively investing in Research and Development initiatives. These initiatives aim to enhance these imaging technologies. For instance, the adoption of next-generation hybrid imaging systems has been noted.

They significantly improve diagnostic precision. This progression not only augments the quality of care provided but also attracts healthcare facilities. This drives market expansion.

### **Government Initiatives and Healthcare Infrastructure Development**

The South Korean government is focused on improving healthcare infrastructure. This serves as a pivotal driver for the South Korea Coronary Angiography Devices Market. Recent government policies have aimed to bolster investment in healthcare facilities.

This is particularly in metropolitan areas. The National Health Insurance Service (NHIS) under the government has expanded coverage for coronary interventions. This includes angiography, increasing accessibility for patients.

Moreover, investment in hospitals and clinics for modern medical technologies has been prioritized. This strategic move not only increases the availability of advanced devices. It also leads to wider acceptance and usage in clinical practice, increasing market penetration.

### **Growing Aging Population**

The aging population in South Korea is a significant contributor to market growth. As per Statistics Korea, individuals aged 65 and above are expected to constitute over 24% of the total by 2030. This demographic shift indicates a rising incidence of age-related health issues.

This includes cardiovascular diseases. The elderly population is more susceptible to conditions necessitating coronary angiography. This leads to higher demand for such devices.

Furthermore, organizations like the Korean Geriatric Society are pushing for improved healthcare services. These are tailored to the aging population, which is expected to stimulate further market growth.

## **South Korea Coronary Angiography Devices Market Segment Insights**

### **Coronary Angiography Devices Market Product Type Insights**

The South Korea Coronary Angiography Devices Market showcases a diverse array of product types. These cater to the growing needs of cardiac healthcare. Angiography Catheters play a crucial role, facilitating contrast media delivery and aiding imaging procedures.

This makes them essential tools in diagnosing and treating coronary artery diseases. Additionally, Contrast Media is pivotal as it enhances visibility of blood vessels during angiographic procedures. This is vital for accurate diagnosis and treatment planning.

The Angiography Systems segment is also significant, comprising advanced imaging technology. This propels cardiologists' capabilities by providing detailed views of coronary anatomy. This is crucial for effective intervention strategies.

Meanwhile, Inflatable Balloons are integral in various angioplasty procedures. They offer effective vascular access and enhance the success rate of revascularization. Lastly, Guidewires are vital components that assist in navigating through complex vascular pathways.

They ensure devices reach their intended locations efficiently. Each of these product types contributes to overall efficacy of coronary interventions. They reflect advancements in technology, resonating with increasing demand for minimally invasive procedures.

As the market evolves, innovations in these product categories are expected to address challenges. These challenges are posed by a growing aging population and rising cardiovascular diseases. The synergy among these components drives market growth.

This is achieved by improving clinical outcomes, enhancing patient safety, and streamlining procedural efficiency. Ultimately, this leads to a robust healthcare environment focused on cardiovascular health.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Coronary Angiography Devices Market Application Insights**

The South Korea Coronary Angiography Devices Market is characterized by its diverse application segment. This includes Coronary Angiography, Peripheral Angiography, Neuro Angiography, and Interventional Angiography. The country has a rapidly growing healthcare infrastructure.

This supports advanced diagnostic and therapeutic procedures, significantly impacting market dynamics. Coronary Angiography holds a crucial role due to the country's high incidence of cardiovascular diseases. This necessitates effective imaging technologies.

Peripheral Angiography is also gaining traction as an essential method for diagnosing vascular diseases. This is driven by increasing awareness of related ailments. Neuro Angiography, although a niche segment, is important in addressing neurological disorders.

It enables timely interventions, catering to a specific patient demographic with complex health issues. Interventional Angiography is becoming increasingly significant. It allows for combination diagnostic and therapeutic procedures, enhancing treatment outcomes.

The market is expected to leverage technological advancements and a shift towards personalized medicine. This presents opportunities that can foster significant growth in each application area across the region.

### **Coronary Angiography Devices Market End-user Insights**

The South Korea Coronary Angiography Devices Market, primarily influenced by the End-user segment, encompasses various healthcare facilities. Each plays a crucial role in the management of cardiovascular diseases. Hospitals represent a major segment.

They offer comprehensive care, advanced technologies, and are equipped with skilled professionals to perform angiographic procedures. Ambulatory Surgical Centers are gaining traction due to their ability to provide outpatient services. This signifies convenience for patients and lower operational costs.

Diagnostic Imaging Centers are essential in diagnosing and assessing cardiac conditions, facilitating early intervention. Specialty Clinics cater to specific patient needs, often focusing on cardiovascular health. The increasing prevalence of heart diseases in South Korea boosts demand for these medical facilities.

This emphasizes the importance of timely and efficient treatment. Moreover, government initiatives and investments in healthcare infrastructure further enhance capabilities. This creates a favorable environment for market growth.

As the healthcare landscape evolves, each End-user category adapts to emerging technologies and standards. This ensures comprehensive cardiac care for the population.

### **Coronary Angiography Devices Market Technology Insights**

The South Korea Coronary Angiography Devices Market, under the Technology segment, showcases diverse advancements. These cater to the growing demand for accurate cardiovascular imaging. Digital Angiography has emerged as a prominent technology.

This is due to its efficiency and high-resolution imaging capabilities. It allows for quicker and more precise diagnoses. Computed Tomography Angiography is also gaining traction.

It leverages its non-invasive nature and ability to visualize coronary arteries in detail. This is crucial for timely interventions. Additionally, Magnetic Resonance Angiography is significant.

It provides a radiation-free alternative, promoting patient safety while delivering high-quality images. As health concerns regarding cardiovascular diseases escalate in South Korea, emphasis on advanced imaging technologies is high. This presents opportunities for market players to innovate and expand their offerings.

The preference for minimally invasive procedures is shaping demand for these technologies. This provides a pathway for growth and improvement in patient outcomes. Ongoing research and development initiatives in these segments promise to enhance efficacy.

This will address the region's healthcare needs.

## **South Korea Coronary Angiography Devices Market Key Players and Competitive Insights**

The South Korea Coronary Angiography Devices Market reveals a landscape characterized by rapid technological advancements. It also shows heightened competition among key players. This market focuses on development, production, and distribution of devices.

These are essential for coronary angiography procedures, vital for diagnosing and treating cardiovascular diseases. With increasing prevalence of heart-related ailments and a growing aging population, demand has surged. Competitive dynamics are influenced by regulatory approvals, technological innovations, and strategic partnerships.

Companies operating in this segment are continually enhancing product portfolios. They invest significantly in research and development to maintain a competitive edge. This addresses the ever-evolving healthcare needs of South Korea.

Abbott stands out with a solid reputation for delivering high-quality and reliable medical devices. The company leverages its extensive experience in the healthcare sector. It focuses on innovative solutions that cater to cardiologists and healthcare professionals.

Abbott has made significant inroads in South Korea. It provides advanced devices and ensures rigorous quality control and compliance. Their robust R&D capabilities allow continuous launch of device enhancements.

This addresses demands for precision and efficiency in coronary imaging. Abbott's strong distribution networks, coupled with strategic collaborations, augment market presence. This establishes them as a formidable player in the coronary angiography sector.

Philips also holds a noteworthy position, highlighting its focus on integrated healthcare solutions. The company is well-known for its advanced imaging technologies. These include state-of-the-art angiography systems tailored for optimal performance.

Philips emphasizes innovation through its commitment to research and development. It consistently introduces products that enhance diagnostic accuracy and improve patient outcomes. With a strong market presence, Philips benefits from a reputation for high-quality equipment.

The company has engaged in various collaborations and potential mergers. These have facilitated the introduction of cutting-edge technology. Their offerings extend beyond imaging devices, encompassing comprehensive services.

These support hospitals and clinics throughout the patient care continuum. Philips continues to capitalize on its strengths, maintaining a prominent role.

### **Key Companies in the South Korea Coronary Angiography Devices Market Include**

- [Abbott](https://www.cardiovascular.abbott/us/en/hcp/products/percutaneous-coronary-intervention/coronary-physiology.html)
- Philips
- Boston Scientific
- Medtronic
- Stryker
- Asahi Intecc
- Terumo
- Cardinal Health
- Edwards Lifesciences
- Volcano Corporation
- Johnson & Johnson
- B. Braun
- Siemens Healthineers
- GE Healthcare
- Cook Medical

### **South Korea Coronary Angiography Devices Market Developments**

The South Korea Coronary Angiography Devices Market has seen noteworthy developments recently. A significant focus on enhancing cardiovascular care has been noted. Companies like Abbott, Boston Scientific, and Medtronic are launching innovative systems.

These ensure more accurate diagnostics and treatment. In October 2023, GE Healthcare announced a new advanced imaging system. This is specifically designed for coronary procedures, aiming to streamline workflow.

The market is experiencing growth, driven by increasing prevalence of cardiovascular diseases. Rising demand for innovative diagnostic tools also contributes. Additionally, there have been discussions on potential collaborations among major players.

This includes Siemens Healthineers and Terumo, to enhance their portfolios in this niche market. Notably, Boston Scientific reportedly completed a local start-up acquisition in September 2023. This focuses on minimally invasive angiography technologies, highlighting consolidation and innovation.

The South Korean government continues to invest in healthcare infrastructure. This signals a promising environment for cardiovascular technology developments. Emphasis is placed on Research and Development to improve patient care and health outcomes.

## **South Korea Coronary Angiography Devices Market Segmentation Insights**

### **Coronary Angiography Devices Market Product Type Outlook**

- Angiography Catheters
- Contrast Media
- Angiography Systems
- Inflatable Balloons
- Guidewires

### **Coronary Angiography Devices Market Application Outlook**

- Coronary Angiography
- Peripheral Angiography
- Neuro Angiography
- Interventional Angiography

### **Coronary Angiography Devices Market End-user Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Specialty Clinics

### **Coronary Angiography Devices Market Technology Outlook**

- Digital Angiography
- Computed Tomography Angiography
- Magnetic Resonance Angiography

## Market Drivers

### Increased Healthcare Expenditure

South Korea's commitment to enhancing its healthcare infrastructure is evident through rising healthcare expenditures. The government has allocated substantial budgets to improve medical facilities and technologies, which directly benefits the coronary angiography-devices market. With healthcare spending reaching around 8% of GDP, there is a notable investment in advanced medical equipment, including angiography devices. This financial support enables hospitals and clinics to acquire state-of-the-art technology, thereby improving patient outcomes. Furthermore, the emphasis on early diagnosis and preventive care is likely to drive the adoption of these devices, as healthcare providers aim to reduce long-term treatment costs associated with cardiovascular diseases.

### Growing Awareness of Preventive Healthcare

There is a notable shift in public perception towards preventive healthcare in South Korea, which significantly impacts the coronary angiography-devices market. As individuals become more health-conscious, there is an increasing demand for regular health screenings and diagnostic procedures. This trend is reflected in the rising number of health check-ups and screenings offered by hospitals and clinics. Consequently, the market for coronary angiography devices is likely to expand as more patients seek early detection of potential heart issues. Educational campaigns and initiatives by health organizations further promote awareness, encouraging individuals to prioritize their cardiovascular health and seek timely interventions.

### Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases in South Korea is a primary driver for the coronary angiography-devices market. According to health statistics, cardiovascular diseases account for a significant portion of mortality rates, prompting healthcare providers to seek advanced diagnostic tools. The demand for coronary angiography devices is expected to rise as more patients require accurate assessments of their heart health. This trend is further supported by the aging population, which is more susceptible to heart-related ailments. As a result, the market is projected to grow at a compound annual growth rate (CAGR) of approximately 7% over the next few years, reflecting the urgent need for effective diagnostic solutions in the healthcare system.

### Regulatory Support for Medical Device Approvals

The regulatory environment in South Korea plays a crucial role in shaping the coronary angiography-devices market. The government has implemented streamlined processes for the approval of medical devices, which encourages innovation and expedites the introduction of new technologies. This supportive regulatory framework allows manufacturers to bring advanced coronary angiography devices to market more efficiently. As a result, healthcare providers gain access to the latest diagnostic tools, which can improve patient care. The proactive stance of regulatory bodies in promoting medical device advancements is likely to foster growth in the coronary angiography-devices market, as it aligns with the broader goals of enhancing healthcare quality and accessibility.

### Technological Innovations in Imaging Techniques

The coronary angiography devices market is experiencing a surge in technological innovations that enhance imaging techniques. Advancements such as 3D imaging, real-time visualization, and improved contrast agents are revolutionizing the way cardiovascular conditions are diagnosed. These innovations not only improve the accuracy of diagnoses but also reduce the risks associated with traditional procedures. As healthcare providers in South Korea adopt these cutting-edge technologies, the demand for advanced coronary angiography devices is expected to rise. The integration of artificial intelligence and machine learning in imaging analysis further indicates a promising future for the market, as these technologies streamline workflows and enhance diagnostic precision.

## Future Outlook

The [Coronary Angiography Devices Market](https://www.marketresearchfuture.com/reports/coronary-angiography-devices-market-6151) is projected to grow at a 12.22% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

**New opportunities:**

- Development of AI-driven imaging software for enhanced diagnostic accuracy.
- Expansion of telehealth services for remote patient monitoring and consultations.
- Partnerships with hospitals for integrated device management solutions.

By 2035, the market is expected to achieve substantial growth, reflecting robust demand and innovation.

## Segment Insights

### By Type: Angiography Systems (Largest) vs. Angiography Catheters (Fastest-Growing)

The South Korea coronary angiography-devices market showcases a diverse distribution of segment values, with the largest share held by Angiography Systems. Angiography Systems have proven essential for diagnostic purposes and therapeutic interventions, thus underlining their dominance. In contrast, Angiography Catheters have emerged as the fastest-growing segment, driven by innovations in design and enhancements in patient outcomes, signifying a shift towards more effective cardiovascular treatments.

Growth trends within this segment reflect an increasing demand for advanced imaging technologies and minimally invasive procedures. The rise in cardiac diseases and the aging population bolster the need for reliable and efficient angiography devices. Additionally, innovations such as digital imaging and improvements in catheter technology are anticipated to fuel further expansion in the Angiography Catheters segment, positioning it as a crucial player in the market moving forward.

Angiography Systems (Dominant) vs. Angiography Catheters (Emerging)

Angiography Systems represent the dominant segment within the South Korea coronary angiography-devices market, characterized by their advanced imaging capabilities and essential role in diagnosis and treatment planning. These systems incorporate cutting-edge technology, enabling high-resolution images and facilitating swift decision-making. On the other hand, the Angiography Catheters segment is emerging rapidly, propelled by modern advancements in catheter designs that promote enhanced maneuverability and effectiveness in vascular access. These catheters are increasingly preferred for their minimized risk and improved patient comfort, indicating a significant shift in procedural practices. As both segments evolve, they cater to varying needs in the clinical landscape, with Angiography Systems leading the way and Angiography Catheters gaining momentum.

### By Application: Coronary Angiography (Largest) vs. Peripheral Angiography (Fastest-Growing)

In the South Korea coronary angiography-devices market, the distribution of market share among the application segments is notably diverse. Coronary Angiography holds the largest share, mainly driven by its extensive use in diagnosing coronary artery diseases. In contrast, Peripheral Angiography is witnessing a rapid rise in demand, propelled by increasing awareness and prevalence of peripheral vascular diseases. The Neuro Angiography and Interventional Angiography segments, while smaller, also contribute to the overall growth and diversification of the market, reflecting advancements in technology and clinical applications.

The growth trends in this segment are largely influenced by technological advancements and a rising aging population. The demand for minimally invasive procedures has driven innovation in devices for both Coronary and Peripheral Angiography. Additionally, the increasing incidence of lifestyle-related diseases in South Korea is fueling the need for efficient diagnostic solutions. As healthcare professionals increasingly adopt advanced angiography techniques, the market is expected to expand significantly, with Peripheral Angiography emerging as a key area of focus due to its potential for rapid growth.

Coronary Angiography (Dominant) vs. Neuro Angiography (Emerging)

Coronary Angiography currently dominates the South Korea coronary angiography-devices market, attributed to its critical role in diagnosing and managing heart conditions. This segment showcases robust adoption rates due to the prevalence of coronary artery diseases among the population. Its dominance is characterized by the availability of state-of-the-art imaging technology and the presence of skilled healthcare professionals. Conversely, the Neuro Angiography segment is emerging, gaining traction with advancements in neurovascular treatments and increasing incidence of neurovascular disorders. The development of innovative devices aimed at enhancing diagnostic accuracy and treatment efficacy within this segment presents significant growth opportunities, potentially capturing a larger market share in the forthcoming years.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the South Korea coronary angiography-devices market, Hospitals dominate the end user segment, holding a significant share due to their comprehensive healthcare services and advanced technology. Ambulatory Surgical Centers are also notable, experiencing rapid growth as they provide cost-effective and efficient alternatives for cardiovascular procedures, gradually increasing their market presence. 

The growth of the end user segment is driven by increasing cardiovascular diseases, technological advancements, and a shift towards minimally invasive procedures. Hospitals continue to invest heavily in the latest angiography technology, while Ambulatory Surgical Centers are capitalizing on the trend of outpatient care, which allows patients to receive high-quality treatments with shorter recovery times, thus attracting more users.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals in the South Korea coronary angiography-devices market are characterized by their extensive facilities and skilled workforce, allowing them to provide a wide range of cardiac care services, including angiography. Their established infrastructure and reputation contribute to their dominant position. In contrast, Ambulatory Surgical Centers represent an emerging segment, focusing on providing more convenient and affordable treatment options. They are adapting quickly to technological improvements, catering to the increasing demand for outpatient services, and positioning themselves as viable alternatives to traditional hospital settings. This shift is reflective of broader trends in healthcare emphasizing efficiency and patient-centered care.

### By Technology: Digital Angiography (Largest) vs. Computed Tomography Angiography (Fastest-Growing)

In the South Korea coronary angiography-devices market, Digital Angiography holds the largest share, driven by its widespread adoption and advanced imaging capabilities. This technology is recognized for providing high-resolution images, which are crucial for accurate diagnosis and treatment planning. Meanwhile, Computed Tomography Angiography is rapidly gaining traction, appealing to healthcare providers looking for faster and less invasive imaging options.

The growth trends in this segment are influenced by technological advancements and increasing healthcare investments. The demand for minimally invasive procedures is propelling the growth of Computed Tomography Angiography, making it an attractive option in modern clinical practices. Additionally, the integration of artificial intelligence in imaging technologies enhances diagnostic confidence and efficiency, further driving market expansion.

Technology: Digital Angiography (Dominant) vs. Computed Tomography Angiography (Emerging)

Digital Angiography remains the dominant technology in the market due to its established reliability and extensive application in diagnostic imaging. This method utilizes digital subtraction to enhance image clarity and reduce the need for contrast agents, thus minimizing patient risk. On the other hand, Computed Tomography Angiography is emerging as a strong alternative, appealing to clinicians who prioritize speed and patient comfort. Its ability to create 3D images allows for better visualization of vascular structures. Both technologies reflect a shift towards more patient-centered and precise diagnostic tools, emphasizing their significance in the evolving landscape of cardiovascular care.

## Competitive Benchmarking

The [coronary angiography-devices market](https://www.marketresearchfuture.com/reports/coronary-angiography-devices-market-6151) in South Korea is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an aging population, increasing prevalence of cardiovascular diseases, and advancements in medical technology. Major players such as Abbott (US), Boston Scientific (US), and Medtronic (US) are strategically positioned to leverage these trends. Abbott (US) focuses on innovation in imaging technologies, while Boston Scientific (US) emphasizes expanding its product portfolio through strategic acquisitions. Medtronic (US) is enhancing its operational focus on digital health solutions, which collectively shapes a competitive environment that is increasingly reliant on technological advancements and strategic partnerships.
In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of South Korea's robust manufacturing capabilities. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and innovations, fostering competition that drives continuous improvement in quality and technology.
In October 2025, Abbott (US) announced the launch of a new imaging system designed to enhance the precision of coronary angiography procedures. This strategic move is significant as it not only reinforces Abbott's commitment to innovation but also positions the company to capture a larger market share by addressing the growing demand for advanced imaging solutions. The introduction of this technology is likely to enhance procedural outcomes and patient safety, thereby strengthening Abbott's competitive edge.
In September 2025, Boston Scientific (US) completed the acquisition of a smaller firm specializing in catheter-based technologies. This acquisition is indicative of Boston Scientific's strategy to broaden its product offerings and enhance its technological capabilities. By integrating these new technologies, the company aims to improve its competitive positioning in the coronary angiography segment, potentially leading to increased market penetration and revenue growth.
In August 2025, Medtronic (US) launched a new digital platform aimed at streamlining the workflow of angiography procedures. This initiative reflects Medtronic's focus on digital transformation and the integration of artificial intelligence (AI) into healthcare solutions. The platform is expected to improve efficiency and accuracy in procedures, thereby enhancing patient outcomes and solidifying Medtronic's role as a leader in the market.
As of November 2025, current competitive trends are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and collaboration. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and enhanced patient care solutions. This shift suggests that companies that prioritize these aspects will be better positioned to thrive in the evolving market.

## Recent News & Developments

The South Korea Coronary Angiography Devices Market has seen noteworthy developments recently. A significant focus on enhancing cardiovascular care has been noted. Companies like Abbott, Boston Scientific, and Medtronic are launching innovative systems.

These ensure more accurate diagnostics and treatment. In October 2023, GE Healthcare announced a new advanced imaging system. This is specifically designed for coronary procedures, aiming to streamline workflow.

The market is experiencing growth, driven by increasing prevalence of cardiovascular diseases. Rising demand for innovative diagnostic tools also contributes. Additionally, there have been discussions on potential collaborations among major players.

This includes Siemens Healthineers and Terumo, to enhance their portfolios in this niche market. Notably, Boston Scientific reportedly completed a local start-up acquisition in September 2023. This focuses on minimally invasive angiography technologies, highlighting consolidation and innovation.

The South Korean government continues to invest in healthcare infrastructure. This signals a promising environment for cardiovascular technology developments. Emphasis is placed on Research and Development to improve patient care and health outcomes.

## Report Scope

| MARKET SIZE 2024 | 300.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 336.66(USD Million) |
| MARKET SIZE 2035 | 1066.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.22% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott (US), Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Cardinal Health (US), Terumo (JP), B. Braun (DE) |
| Segments Covered | Type, Application, End User, Technology |
| Key Market Opportunities | Advancements in imaging technologies enhance diagnostic accuracy in the coronary angiography-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in South Korea's coronary angiography-devices market. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What is the current valuation of the coronary angiography-devices market in South Korea?**
A: The market valuation was $300.0 Million in 2024.

**Q: What is the projected market size for the coronary angiography-devices market by 2035?**
A: The projected valuation for 2035 is $1066.0 Million.

**Q: What is the expected CAGR for the coronary angiography-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 12.22%.

**Q: Which companies are the key players in the coronary angiography-devices market?**
A: Key players include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Philips, GE Healthcare, Cardinal Health, Terumo, and B. Braun.

**Q: What segment had the highest valuation in the coronary angiography-devices market in 2024?**
A: Angiography Systems had the highest valuation at $120.0 Million.

**Q: How much is the coronary angiography segment expected to grow by 2035?**
A: The coronary angiography segment is projected to grow from $120.0 Million in 2024 to $426.0 Million by 2035.

**Q: What is the valuation of the contrast media segment in 2024?**
A: The contrast media segment was valued at $50.0 Million in 2024.

**Q: Which end user segment is expected to dominate the market by 2035?**
A: Hospitals are expected to dominate, growing from $120.0 Million in 2024 to $420.0 Million by 2035.

**Q: What technology segment is projected to have the highest growth by 2035?**
A: Computed Tomography Angiography is projected to grow from $120.0 Million in 2024 to $440.0 Million by 2035.

**Q: What is the valuation of the inflatable balloons segment in 2024?**
A: The inflatable balloons segment was valued at $30.0 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-coronary-angiography-devices-market-56259*
